References
- Ho TH, Barbera L, Saskin R, et al. Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario, Canada. J Clin Oncol. 2011;29:1587–1591.
- Barbera L, Paszat L, Chartier C. Indicators of poor quality end-of-life cancer care in Ontario. J Palliat Care. 2006;22:12–17.
- Earle CC, Landrum MB, Souza JM, et al. Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol. 2008;26:3860–3866.
- Barnato AE, McClellan MB, Kagay CR, et al. Trends in inpatient treatment intensity among Medicare beneficiaries at the end of life. Health Serv Res. 2004;39:363–375.
- Cheung MC, Earle CC, Rangrej J, et al. Impact of aggressive management and palliative care on cancer costs in the final month of life. Cancer. 2015;121:3307–3315.
- Howell DA, Roman E, Cox H, et al. Destined to die in hospital? Systematic review and meta-analysis of place of death in haematological malignancy. BMC Palliat Care. 2010;9:9.
- Hui D, Didwaniya N, Vidal M, et al. Quality of end-of-life care in patients with hematologic malignancies: a retrospective cohort study. Cancer. 2014;120:1572–1578.
- Odejide OO, Cronin AM, Earle CC, et al. Why are patients with blood cancers more likely to die without hospice? Cancer. 2017;123:3377–3384.
- Kinoshita H, Maeda I, Morita T, et al. Place of death and the differences in patient quality of death and dying and caregiver burden. J Clin Oncol. 2015;33:357–363.
- Teno JM, Clarridge BR, Casey V, et al. Family perspectives on end-of-life care at the last place of care. JAMA. 2004;291:88–93.
- Gomes B, Higginson IJ, Calanzani N, et al. Preferences for place of death if faced with advanced cancer: a population survey in England, Flanders, Germany, Italy, the Netherlands, Portugal and Spain. Ann Oncol. 2012;23:2006–2015.
- Groff AC, Colla CH, Lee TH. Days spent at home – a patient-centered goal and outcome. N Engl J Med. 2016;375:1610–1612.
- Sayer C. “Time spent at home” – a patient-defined outcome. NEJM Catalyst. 2016. Available from: http://catalyst.nejm.org/time-spent-at-home-a-patient-defined-outcome
- Andersen SK, Croxford R, Earle CC, et al. Days at home in the last 6 months of life: a patient-determined quality indicator for cancer care. J Oncol Prac. 2019;15:e308–e315.
- Odejide OO, Cronin AM, Condron NB, et al. Barriers to quality end-of-life care for patients with blood cancers. J Clin Oncol. 2016;34:3126–3132.
- Austin PC, van Walraven C, Wodchis WP, et al. Using the Johns Hopkins Aggregated Diagnosis Groups (ADGs) to predict mortality in a general adult population cohort in Ontario, Canada. Med Care. 2011;49:932–939.
- Health Quality Ontario. Palliative care at the end of life. Toronto: Queen’s Printer for Ontario; 2016 [cited 2019 May 1]. Available from: http://www.hqontario.ca/Portals/0/documents/system-performance/palliative-care-report-en.pdf
- Austin PC, Tu JV, Daly PA, et al. The use of quantile regression in health care research: a case study examining gender differences in the timeliness of thrombolytic therapy. Stat Med. 2005;24:791–816.
- Earle CC, Park ER, Lai B, et al. Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol. 2003;21:1133–1138.
- Earle CC, Neville BA, Landrum MB, et al. Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol. 2004;22:315–321.
- Saeed F, Hoerger M, Norton SA, et al. Preference for palliative care in cancer patients: are men and women alike? J Pain Symptom Manage. 2018;56:1–6.e1.
- Sharma RK, Prigerson HG, Penedo FJ, et al. Male-female patient differences in the association between end-of-life discussions and receipt of intensive care near death. Cancer. 2015;121:2814–2820.
- Morgan T, Ann Williams L, Trussardi G, et al. Gender and family caregiving at the end-of-life in the context of old age: a systematic review. Palliat Med. 2016;30:616–624.
- Dahlberg L, Demack S, Bambra C. Age and gender of informal carers: a population-based study in the UK. Health Soc Care Community. 2007;15:439–445.
- Wachterman MW, Sommers BD. The impact of gender and marital status on end-of-life care: evidence from the National Mortality Follow-Back Survey. J Palliat Med. 2006;9:343–352.
- World Health Organization. Women, ageing and health: a framework for action. A focus on gender (report). Geneva, Switzerland: World Health Organization, 2007.
- Manitta VJ, Philip JA, Cole-Sinclair MF. Palliative care and the hemato-oncological patient: can we live together? A review of the literature. J Palliat Med. 2010;13:1021–1025.
- O’Connor NR, Hu R, Harris PS, et al. Hospice admissions for cancer in the final days of life: independent predictors and implications for quality measures. J Clin Oncol. 2014;32:3184–3189.
- Howell DA, Shellens R, Roman E, et al. Haematological malignancy: are patients appropriately referred for specialist palliative and hospice care? A systematic review and meta-analysis of published data. Palliat Med. 2011;25:630–641.
- Wang R, Zeidan AM, Halene S, et al. Health care use by older adults with acute myeloid leukemia at the end of life. J Clin Oncol. 2017;35:3417–3424.
- LeBlanc TW, Egan PC, Olszewski AJ. Transfusion dependence, use of hospice services, and quality of end-of-life care in leukemia. Blood. 2018;132:717–726.
- Greer JA, Pirl WF, Jackson VA, et al. Effect of early palliative care on chemotherapy use and end-of-life care in patients with metastatic non-small-cell lung cancer. J Clin Oncol. 2012;30:394–400.
- Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363:733–742.
- Zimmermann C, Swami N, Krzyzanowska M, et al. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet. 2014;383:1721–1730.
- Howell DA, Wang HI, Roman E, et al. Preferred and actual place of death in haematological malignancy. BMJ Support Palliat Care. 2017;7:150–157.